Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters

2009 ◽  
Vol 26 (5) ◽  
pp. 348-355 ◽  
Author(s):  
Hüseyin Demirci ◽  
Murat Yilmaz ◽  
Mehmet Ali Ergun ◽  
Erkan Yurtcu ◽  
Neslihan Bukan ◽  
...  
2005 ◽  
Vol 51 (2) ◽  
pp. 416-423 ◽  
Author(s):  
Nectaria Xita ◽  
Ioannis Georgiou ◽  
Anthoula Chatzikyriakidou ◽  
Maria Vounatsou ◽  
Gerasimos-Peter Papassotiriou ◽  
...  

Abstract Background: We examined the possible association of adiponectin gene polymorphisms with polycystic ovary syndrome (PCOS) and their influence on serum adiponectin and insulin resistance indexes in Greek women with PCOS. Methods: We genotyped samples from 100 women with PCOS characterized with respect to body mass index (BMI), glucose and insulin concentrations during an oral glucose tolerance test (OGTT), lipid profile, and serum adiponectin concentrations and from 140 healthy controls for the 45T>G and 276G>T polymorphisms in the adiponectin gene. Results: The distributions of genotypes and alleles of both polymorphisms were no different in women with PCOS and controls, indicating that the individual polymorphisms are not associated with increased risk for PCOS. However, the two polymorphisms were found to be associated with insulin resistance indexes among women with PCOS and to influence adiponectin production. In particular, carriers of the TG genotype at position +45 had greater hyperinsulinemia, as estimated by the area under the curve for insulin (AUCinsulin) during the OGTT, than those with the TT genotype (P <0.05), and this was independent of age and BMI. In addition, women with PCOS with the GG or GT genotypes at position +276 had a higher BMI (P = 0.01) and greater AUCinsulin (P = 0.01) than carriers of the TT genotype. The latter genotype was found less frequently among overweight/obese women with PCOS than in normal-weight individuals (P = 0.002). In addition, the presence of the GG or GT genotype was associated with lower serum adiponectin than the TT genotype, independent of age, BMI, and insulin concentrations (P = 0.03). Serum adiponectin was negatively correlated with serum triglycerides and insulin resistance indexes and positively with HDL-cholesterol. Conclusions: Adiponectin gene polymorphisms at positions +45 and +276 are not associated with PCOS. However, these genomic variants may influence production of adiponectin and the metabolic variables related to insulin resistance/metabolic syndrome in patients with PCOS.


2014 ◽  
Vol 101 (5) ◽  
pp. 1419-1423.e3 ◽  
Author(s):  
Wenjuan Zhang ◽  
Daimin Wei ◽  
Xianchang Sun ◽  
Jing Li ◽  
Xinyan Yu ◽  
...  

1995 ◽  
Vol 133 (6) ◽  
pp. 718-722 ◽  
Author(s):  
Antonino Lasco ◽  
Domenico Cucinotta ◽  
Alfonso Gigante ◽  
Giulia Denuzzo ◽  
Marilena Pedulla ◽  
...  

Lasco A, Cucinotta D, Gigante A, Denuzzo G, Pedulla M, Trifiletti A, Frisina N. No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide. Eur J Endocrinol 1995;133:718–22. ISSN 0804–4643 The aim of this study was to investigate the relationship between plasma insulin levels, peripheral insulin sensitivity and androgen secretion in ten patients with polycystic ovary syndrome and in six obese women as compared with six normal-weight control subjects. During a euglycemic–hyperinsulinemic clamp no significant change of testosterone, androstenedione or dehydroepiandrosterone sulfate plasma levels was observed in the two groups of patients or in the control subjects; insulin sensitivity was clearly reduced and was similar in polycystic ovary patients and in obese women, in spite of the different plasma androgen levels. A long-term (5 months) androgen suppression with the gonadotropin-releasing hormone agonist leuprolide was not able to improve significantly the insulin sensitivity. These results demonstrate that the short-term hyperinsulinemia achieved with the clamp technique does not affect androgen secretion and that insulin resistance, measured with the same technique, is not influenced by long-term suppression of plasma androgen levels in polycystic ovary syndrome. A Lasco, Via Faustina e Tertullo 19, 98100 Messina, Italy


2006 ◽  
Vol 30 (2) ◽  
pp. 104 ◽  
Author(s):  
Young-A Kim ◽  
Jung-Hyun Noh ◽  
Dong-Jun Kim ◽  
Tae-Hyun Um ◽  
Chong-Rae Cho ◽  
...  

2008 ◽  
Vol 89 (4) ◽  
pp. 899-906 ◽  
Author(s):  
Dimitrios Panidis ◽  
Dimitrios Farmakiotis ◽  
David Rousso ◽  
Anargyros Kourtis ◽  
Ilias Katsikis ◽  
...  

Endocrine ◽  
2012 ◽  
Vol 42 (2) ◽  
pp. 299-306 ◽  
Author(s):  
Hongxia Jia ◽  
Lili Yu ◽  
Xuxiao Guo ◽  
Wei Gao ◽  
Zhaoshun Jiang

Sign in / Sign up

Export Citation Format

Share Document